Kromek Group PLC Result of AGM (0223O)

TIDMKMK

RNS Number : 0223O

Kromek Group PLC

28 September 2023

Kromek Group plc

("Kromek" or the "Group")

Result of AGM

Kromek Group plc, a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that at its Annual General Meeting ("AGM"), held earlier today, all resolutions were duly passed.

Details of the proxy voting results, which should be read alongside the Notice of AGM, are below:

 
 Resolution          Votes for                Votes against          Votes        Total 
                                                                    withheld    proxy votes 
                No. of      % of votes     No. of     % of votes    No. of 
                 votes         cast*        votes        cast*       votes 
             ------------  -----------  -----------  -----------  ----------  ------------- 
     1        189,476,538     94.43      11,176,883      5.57       217,336    200,870,757 
             ------------  -----------  -----------  -----------  ----------  ------------- 
     2        179,826,325     90.14      19,674,285      9.86      1,370,147   200,870,757 
             ------------  -----------  -----------  -----------  ----------  ------------- 
     3        182,008,714     91.33      17,274,285      8.67      1,587,758   200,870,757 
             ------------  -----------  -----------  -----------  ----------  ------------- 
     4        198,554,316     99.71       582,433        0.29      1,734,008   200,870,757 
             ------------  -----------  -----------  -----------  ----------  ------------- 
     5        199,638,889     99.60       806,687        0.40       425,181    200,870,757 
             ------------  -----------  -----------  -----------  ----------  ------------- 
     6        198,643,359     98.98      2,051,977       1.02       175,421    200,870,757 
             ------------  -----------  -----------  -----------  ----------  ------------- 
     7        191,067,728     96.32      7,295,934       3.68      2,507,095   200,870,757 
             ------------  -----------  -----------  -----------  ----------  ------------- 
     8        187,184,965     93.34      13,353,050      6.66       332,742    200,870,757 
             ------------  -----------  -----------  -----------  ----------  -------------

*Excludes withheld votes

For further information, please contact:

 
Kromek Group plc 
Arnab Basu, CEO 
 Paul Farquhar, CFO                            +44 (0)1740 626 060 
 
Cavendish Capital Markets Limited (Nominated 
 Adviser and Broker) 
Geoff Nash/Giles Balleny/Seamus Fricker - 
 Corporate Finance 
 Tim Redfern/Charlotte Sutcliffe - ECM         +44 (0)20 7220 0500 
Michael Johnson/Tamar Cranford-Smith - Sales 
Gracechurch Group (Financial PR) 
Harry Chathli/Claire Norbury/Henry Gamble      +44 (0)20 4582 3500

Kromek Group plc

Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.

The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.

In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation and solid-state readout technology, are primarily used to protect critical infrastructure, events, personnel and urban environments from the threat of 'dirty bombs'.

The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.

Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGEAENPAADDEFA

(END) Dow Jones Newswires

September 28, 2023 06:25 ET (10:25 GMT)

Kromek (LSE:KMK)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024